N/A
N=301
Pay-it-forward RCT for Gonorrhea and Chlamydia Testing
Gonorrhea Male · Chlamydia;M
Bottom Line
View on ClinicalTrials.gov: NCT03741725 ↗Enrolled (actual)
301
Serious AEs
0.0%
Results posted
Jan 2020
Primary outcome: Primary: Number of Participants Who Received the Dual Gonorrhea/Chlamydia Testing — 57; 46; 18 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Pay-it-forward (Other); Pay-what-you-want (Other)
- Age
- Pediatric, Adult, Older Adult · 16+ yrs
- Sex
- Male
- Sponsor
- University of North Carolina, Chapel Hill
- Primary completion
- Sep 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Received the Dual Gonorrhea/Chlamydia Testing |
57; 46; 18 | — |
| SECONDARY Number of Participants Tested Positive for Gonorrhea |
1; 2; 2 | — |
| SECONDARY Number of Participants Tested Positive for Chlamydia |
8; 8; 3 | — |
| SECONDARY Cost Per Test |
11.24; 9.67; 6.12; 6.52; 6.56; 1.46 | — |
| SECONDARY Cost Per Diagnosis |
11.24; 9.67; 6.12; 6.52; 6.56; 1.46 | — |
| SECONDARY Number of Participants Reporting Community Engagement Activities |
78; 64; 61; 17; 28; 29 | — |
| SECONDARY Community Connectedness Scale Scores |
3.32; 3.05; 3.10; 3.16; 3.00; 3.00 | — |
| SECONDARY Social Cohesion Scale Scores |
2.52; 2.57; 2.64; 2.98; 2.86; 2.98 | — |
Summary
This is a randomized controlled trial which will evaluate dual gonorrhea/chlamydia test uptake and other outcomes in men who have sex with men (MSM) in three trial arms - 1) a pay-it-forward testing arm, 2) a pay-what-you-want testing arm, and 3) standard of care arm.
Eligibility Criteria
Inclusion criteria
- born biologically male
- age 16 years or older
- report previous anal sex with another man
- willing to provide mobile phone number for results notification
Exclusion criteria
- tested for both gonorrhoea and chlamydia in the past 12 months with no high-risk sexual behavior following testing
- previous participation in pay-it-forward program
Data sourced from ClinicalTrials.gov (NCT03741725). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.